enbucrilate has been researched along with epirubicin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balansky, RM; Blagoeva, PM; Mircheva, TJ; Simeonova, MI | 1 |
Antcheva, MN; Simeonova, MY | 1 |
Evangelatov, A; Skrobanska, R; Yordanov, G | 2 |
Evangelatov, A; Mladenov, N; Pankov, R; Petkova, M; Skrobanska, R; Yordanov, G | 1 |
Lau, WY; Lei, Z; Li, J; Shen, F; Si, A; Wan, X; Wang, K; Wang, Q; Wang, Y; Wu, D; Wu, M; Xia, Y; Yan, Z | 1 |
6 other study(ies) available for enbucrilate and epirubicin
Article | Year |
---|---|
Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles.
Topics: Animals; Bone Marrow; Drug Carriers; Enbucrilate; Epirubicin; Female; Liver; Maternal-Fetal Exchange; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mitomycin; Mutagenicity Tests; Mutagens; Pregnancy; Salmonella typhimurium | 1992 |
Effect of farmorubicin both free and associated with poly(butylcyanoacrylate) nanoparticles on phagocytic and NK activity of peritoneal exudate cells from tumor-bearing mice.
Topics: Animals; Antibiotics, Antineoplastic; Ascitic Fluid; Carcinoma, Lewis Lung; Drug Carriers; Enbucrilate; Epirubicin; Female; Humans; K562 Cells; Killer Cells, Natural; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplasm Transplantation; Particle Size; Phagocytosis | 2007 |
Entrapment of epirubicin in poly(butyl cyanoacrylate) colloidal nanospheres by nanoprecipitation: formulation development and in vitro studies on cancer cell lines.
Topics: Cell Death; Cell Line, Tumor; Cell Survival; Chemical Precipitation; Chemistry, Pharmaceutical; Colloids; Dialysis; Enbucrilate; Epirubicin; Humans; Hydrogen-Ion Concentration; Microscopy, Fluorescence; Microscopy, Interference; Nanospheres; Particle Size | 2012 |
Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Cell Line, Tumor; Chemistry, Pharmaceutical; Colloids; Drug Screening Assays, Antitumor; Enbucrilate; Endocytosis; Epirubicin; Humans; Light; Lung Neoplasms; Microscopy, Fluorescence; Nanoparticles; Particle Size; Polymerization; Scattering, Radiation; Static Electricity | 2013 |
Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
Topics: Apoptosis; Carcinoma; Caspase 3; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Enbucrilate; Endocytosis; Epirubicin; Female; HeLa Cells; Humans; Nanoparticles; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2016 |
Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
Topics: Adult; Aged; Chemoembolization, Therapeutic; Cholangiocarcinoma; Enbucrilate; Epirubicin; Female; Fluorouracil; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors | 2015 |